A late-stage drug development company specialized in oncology and endocrinology.

Juergen Engel, Ph. D., President and CEO of Aeterna Zentaris stated, 'We are very pleased with AEZS-108 gaining orphan medicinal product designation for ovarian cancers from European authorities, specifically after having been recently granted orphan-drug designation by the FDA. This means that with both these orphan designations, AEZS-108 will be given extra market exclusivity safety in Europe and also in the United States for the treatment of ovarian cancer. We have now look forward to reporting the final outcomes from our ongoing European Phase 2 research in ovarian and endometrial malignancy, later this year.'.. Aeterna Zentaris' AEZS-108 receives orphan medicinal item designation for ovarian tumor in Europe Aeterna Zentaris Inc.Individuals can either enrol in a beginners or advanced class with respect to the level of fitness they possess. All the best!. Aimee Copeland recovering in high spirits Flesh-eating bacteria victim Aimee Copeland is currently recovering at a rehab facility in the Atlanta area and has a positive outlook, regarding to her parents. She was in high spirits, Copeland's mom, Donna, tODAY told. She couldn't wait to make it happen and to begin. She actually is just so motivated. Monday to start out rehab Aimee Copeland to leave hospital, father says Flesh-eating bacterias victim Aimee Copeland leaves hospital room for first-time in 49 times Aimee Copeland leaves Ga.